Moderna, Inc. (MRNA)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 46.82B |
| Enterprise value | 39.53B |
| Trailing P/E | 7.06 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 9.16 |
| Price/book (mrq) | 3.65 |
| Enterprise value/revenue | 7.78 |
| Enterprise value/EBITDA | 4.64 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.66 |
| 52-week change 3 | 3.78% |
| S&P500 52-week change 3 | 18.96% |
| 52-week high 3 | 170.47 |
| 52-week low 3 | 62.55 |
| 50-day moving average 3 | 134.14 |
| 200-day moving average 3 | 105.40 |
Share statistics
| Avg vol (3-month) 3 | 3.94M |
| Avg vol (10-day) 3 | 2.42M |
| Shares outstanding 5 | 383.24M |
| Implied shares outstanding 6 | 383.24M |
| Float 8 | 345.91M |
| % held by insiders 1 | 9.55% |
| % held by institutions 1 | 72.85% |
| Shares short (15 Jul 2024) 4 | 22.74M |
| Short ratio (15 Jul 2024) 4 | 6.13 |
| Short % of float (15 Jul 2024) 4 | 7.81% |
| Short % of shares outstanding (15 Jul 2024) 4 | 5.93% |
| Shares short (prior month 14 Jun 2024) 4 | 21.6M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -115.82% |
| Operating margin (ttm) | -758.08% |
Management effectiveness
| Return on assets (ttm) | -15.72% |
| Return on equity (ttm) | -37.68% |
Income statement
| Revenue (ttm) | 5.15B |
| Revenue per share (ttm) | 13.52 |
| Quarterly revenue growth (yoy) | -91.00% |
| Gross profit (ttm) | N/A |
| EBITDA | -4.56B |
| Net income avi to common (ttm) | -5.97B |
| Diluted EPS (ttm) | -15.60 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 8.52B |
| Total cash per share (mrq) | 22.24 |
| Total debt (mrq) | 1.24B |
| Total debt/equity (mrq) | 9.65% |
| Current ratio (mrq) | 4.03 |
| Book value per share (mrq) | 33.47 |
Cash flow statement
| Operating cash flow (ttm) | -2.88B |
| Levered free cash flow (ttm) | -1.95B |
© 2024 Yahoo. All rights reserved.